OpenVSafe by OpenVAERS
Search V-safe

6HQ-12416-78017

2 vaccinations 2 coded responses 27 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
902 / CA
Registered
2021-04-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-10
    Registered in v-safe
  2. 2021-04-10
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-10
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  4. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Diarrhea
    Adult check-in
  8. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-17
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  11. 2021-04-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-01
    Health check-in — day 21, single dose
    Feeling: Good
    Adult check-in
  13. 2021-05-08
    Health check-in — day 28, single dose
    Feeling: Good
    Adult check-in
  14. 2021-05-15
    Health check-in — day 35, single dose
    Feeling: Good
    Adult check-in
  15. 2021-05-24
    Health check-in — day 42, single dose
    Feeling: Good
    Adult check-in
  16. 2021-07-10
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  17. 2021-10-11
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  18. 2021-10-25
    Dose 2 — Pfizer-BioNTech
  19. 2021-10-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-10-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  21. 2021-10-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  22. 2021-11-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  23. 2021-11-11
    Survey response — day 14, dose 2
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: A cold, unrelated to vaccine.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-11-15
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-11-29
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-12-06
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-01-24
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-04-25
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-10-27
    Survey response — 12 months, dose 2
    MedDRA: Conjunctivitis, Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Pink eye and a cold
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-10-27
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  32. 2022-10-28

Vaccinations

DoseDateManufacturerCo-administered
12021-04-10Janssen/Johnson & Johnson
22021-10-25Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-27 Unsuccessful

Free text

Release 10 — day 14, dose 2

2021-11-11

Symptoms: A cold, unrelated to vaccine.

Release 12 — 12 months, dose 2

2022-10-27

Symptoms: Pink eye and a cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConjunctivitis · · ✓
SDNasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release